Across TCGA patient cohorts, NAP1L6P RNA expression is significantly associated with the RNA expression of many other genes, with 9,368 significant associations in total. TGCT shows the largest number of these associations.

The most reproducible NAP1L6P-associated genes across cancer lineages are NAP1L2, NAP1L3, and TCEAL2. Each is linked with NAP1L6P in more than 22 cancer types. Because this analysis shows association rather than direction, both NAP1L6P-to-partner and partner-to-NAP1L6P results are reported.

Each partner links to its own Q-omics profile.

RNA expression associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (NAP1L6P→partner) and Y-score (partner→NAP1L6P) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
CHOL	NAP1L2 →	+1.324	+0.759	<.001	.007	1	23
BLCA	NAP1L3 →	+0.860	+0.224	<.001	.006	1	21
STAD	TCEAL2 →	+1.458	+0.188	<.001	<.001	3	18
UCS	ZBED9 →	+0.924	+1.198	<.001	<.001	3	17
GBM	TRAM1L1 →	+0.860	+0.339	<.001	.001	3	17
UCS	KIF5A →	+1.231	+1.166	<.001	.002	1	19

Each partner links to its Q-omics profile. Showing the 6 strongest of 9,368 associations by consensus.

Exploration

NAP1L6P survival (RNA) · tumor vs normal (RNA) · all NAP1L6P data types